WEBSITECHANGES

Website Changes

---

12/29/2023

Musella Foundation awards five more brain tumor research grants!

---

12/29/2023

Gene therapy for brain tumor shows promising early results in humans

---

12/27/2023

In 2024, New Yorkers Will Get Better Access to Biomarker Testing and Precision Medicine

---

12/21/2023

Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma

---

12/20/2023

Meet LI`s Musella Foundation For Brain Tumor Research And Information

---

12/16/2023

Correction on https://costplusdrugs.com/ aritcle

---

12/15/2023

Why Cancer Centers of Excellence May Not Be Right for Every Patient

---

12/14/2023

CostPlus Drug Company now covers Temozolomide(Temodar)!

---

12/13/2023

SonALAsense Presents Preliminary Data From Clinical Study in Patients With Deadly Pediatric Brain Tumor

---

12/13/2023

A father of two diagnosed with Glioblastoma, creates special video with his daughters - sponsored by Novocure

---

12/13/2023

xCures and Aetion® Further Enhance Partnership with Rich Real-World Datasets

---

12/12/2023

Generating Shigella that internalize into glioblastoma cells

---

12/09/2023

Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis

---

12/08/2023

Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients

---

12/05/2023

IQ-AI announces positive results in ongoing GaM study

---

12/05/2023

Researchers hail ‘staggering’ increase in low-grade glioma survival thanks to earlier surgery

---

12/05/2023

Website Problems

---

12/05/2023

‘Kid-first’ startup BrainChild wants to shift the paradigm on pediatric cancer drugs

---

12/05/2023

Highlights From SNO 2023!

---

11/30/2023

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

---

11/28/2023

Celebrate 25 Years of Impact with the Musella Foundation This Giving Tuesday

---

11/21/2023

CAR-T cell therapies infused into brain shrink tumors in two glioblastoma studies

---

11/21/2023

Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society for NeuroOncology

---

11/20/2023

Copay Assistance Program is now open!

---

11/20/2023

GT Medical Technologies, Inc. Presents Use of GammaTile Therapy is Increasing in Time Across Several Brain Tumor Types at the 28th Annual Scientific Meeting and Education Day at the Society of Neuro-Oncology (SNO)

---